Genetic toxicology of abused drugs: A brief review

Mutagenesis

Volumn 13, Issue 6, 1998, Pages 557-565

  Li, Jih Heng ^a,b   Lin, Lih Fang ^a  

^a DEPARTMENT OF HEALTH   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETEL EXTRACT; CANNABIS; COCAINE; CODEINE; DIAMORPHINE; LYSERGIDE; MORPHINE; OPIATE;

CARCINOGENICITY; CATHA EDULIS; DNA DAMAGE; DRUG ABUSE; GENETIC TOXICOLOGY; GENOTOXICITY; HUMAN; PRIORITY JOURNAL; REVIEW;

CANNABIS; CATHA EDULIS; PIPER BETEL;

EID: 0031760631     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/13.6.557     Document Type: Review

References (138)

1. Abrams,C.A.L. (1975) Cytogenetic risks to the offspring of pregnant addicts. Addict. Dis. Int. J., 2, 63-77.
2. Ames,B.N., Durston,W.E., Yamasaki,E. and Lee,F.D. (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl Acad. Sci. USA, 70, 2281-2285.
3. Anderson-Brown,T., Slotkin,T.A. and Seidler,F.J. (1990) Cocaine acutely inhibits DNA synthesis in developing rat brain regions: evidence for direct actions. Brain Res., 537, 197-202.
4. Balint,G.A., Ghbrekidan,H. and Balint,E.E. (1991) Catha edulis, an international socio-medical problem with considerable pharmacological implications. East Afr. Med. J., 68, 555-561.
5. Bartsch,H., Malaveille,C., Camus,A.M., Martel-Planche,G., Hautefeuille,A., Sabadie,N., Barbin,A., Kuroki,T., Drevon,C., Piccoli,C. and Montesano,R. (1980) Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolising systems. Mutat. Res., 76, 1-50.
6. Baylin,S.B. (1997) Tying it all together: epigenetics, genetics, cell cycle, and cancer. Science, 277, 1948-1949.
7. Berryman,S.H., Anderson,R.A.,Jr, Weis,J. and Bartke,A. (1992) Evaluation of the co-mutagenicity of ethanol and delta-9-tetrahydrocannabinol with Trenimon. Mutat. Res., 278, 47-60.
8. Bingol,N., Fuchs,M., Diaz,V., Stone,R.K. and Gromisch,D.S. (1987) Teratogenicity of cocaine in humans. J. Pediat., 110, 93-96.
9. Brady,J.F., Distefano,E.W. and Cho,A.K. (1986) Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine and (+/-)-3, 4-methylenedioxymethamphetamine with rat hepatic microsomes. Life Sci., 39, 1457-1464.
10. Brown,R.M., Friedman,D.P. and Nimit,Y. (eds) (1985) Neuroscience methods in drug abuse research. NIDA Res. Monogr., 62, 1985.
11. Brusick,D. (1978) An evaluation of the genetic effects of heroin (Part A). In National Institute on Drug Abuse, Final Report. National Institute on Drug Abuse, Rockville, MD.
12. Busch,F.W., Seid,D.A. and Wei,E.T. (1979) Mutagenic activity of marihuana smoke condensates. Cancer Lett., 6, 319-324.
13. Caplan,G.A. and Brigham,B.A. (1990) Marijuana smoking and carcinoma of the tongue. Is there an association? Cancer, 66, 1005-1006.
14. Cascales,M., Alvarez,A., Gasco,P., Fernandez-Simon,L., Sanz,N. and Bosca,L. (1994) Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes. Hepatology, 20, 992-1001.
15. Centers for Disease Control and Prevention (1995) Morbidity Mortality Weekly Rep., 44 (4), 64-67.
16. Chasnoff,I.J., Landress,H.J. and Barret,M.E. (1990) The prevalence of illicit drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. New Engl. J. Med., 322, 1202-1206.
17. Chavez,G.F., Mulinare,J. and Cordero,J.F. (1989) Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. J. Am. Med. Ass., 262, 795-798.
18. Cheek,F.E., Newell,S. and Joffee,M. (1970) Deceptions in the illicit drug market. Science, 167, 1276.
19. Cohen,M.M., Maronello,M.J. and Back,N. (1967) Chromosome damage in human leukocytes induced by lysergic acid diethylamide. Science, 155, 1417-1419.
20. Comings,D.E. (1996) Genetic factors in drug abuse and dependence. NIDA Res. Monogr., 159, 16-48.
21. Corey,M.J., Andrews,J.C., McLeod,J., MacLean,J.R. and Wilby,W.E. (1970) Chromosome studies on patients (in vivo) and cells (in vitro) treated with lysergic acid diethylamide. New Engl. J. Med., 282, 939-943.
22. Das,R.K. and Swain,N. (1982) Mutagenic evaluation of morphine sulphate and pethidine hydrochloride in mice by the micronucleus test. Ind. J. Med. Res., 75, 112-117.
23. Dave,B.J., Trivedi,A.H. and Adhvaryu,S.G. (1992) In vitro genotoxic effects of areca nut extract and arecoline. J. Cancer Res. Clin. Oncol., 118, 283-288.
24. De Fonseca,F.R., Carrera,M.R.A., Navarro,M., Koob,G.F. and Weiss,F. (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science, 276, 2050-2054.
25. DeVane,C.L. (1994) Pharmacogenetics and drug metabolism of newer antidepressant agents. J. Clin. Psychiat., 55 (suppl.), 38-45; discussion 46-47.
26. Dishotsky,N.I., Loughman,W.D., Mogar,R.E. and Lipscomb,W.R. (1971) LSD and genetic damage. Science, 172, 431-440.
27. Doll,R. (1990) Lifestyle: an overview. Cancer Detect. Prevent., 14, 589-594.
28. Donahoe.R.M., Madden,J.J., Hollingsworth,F., Shafer,D. and Falek,A. (1985) Morphine depression of T cell E-rosetting: definition of the process. FASEB J., 44, 95-99.
29. Donahoe,R.M., Nicholson,J.K.A., Madden,J.J., Donahoe,F., Shafer,D.A., Gordon,D., Bokos,P. and Falek,A. (1986) Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rossette formation and antigenic marker expression. Clin. Immunol. Immunopathol., 41, 254-264.
30. Egozcue,J., Irwin,S. and Maruffo,C.A. (1968) Chromosomal damage in LSD users. J. Am. Med. Ass., 204, 214-218.
31. Falek,A. and Hollingsworth,I.J. (1980a) Heroin and chromosome damage. Arch. Gen. Psychiat., 37, 227-228.
32. Falek,A. and Hollingsworth,I.J. (1980b) Opiates and human chromosome alterations. Int. J. Addiction, 15, 155-163.
33. Falek,A. and McFadden,I.J. (1973) Cytogenetic follow-up of patients in a methadone maintenance program. Proc. Natl Conf. Methadone Treat., 1.
34. Falek,A., Jordan,R.B., King,B.J., Arnold,P.J. and Skelton,W.D. (1972) Human chromosomes and opiates. Arch. Gen. Psychiat., 27, 511-515.
35. Falek,A., Donahoe,R.M., Madden,J.J. and Shafer,D.A. (1991) Opiates as immunosuppressive and genotoxic agents. Adv. Exp. Med. Biol., 288, 189-201.
36. Fischman,H.K., Moralishvili,E., Joy,C. and Rainer,J.D. (1977) Effects of prolonged administration of 'street' heroin on the chromosomes of Macaco mulatto (rhesus) monkeys. In Roizin,L., Shiraki,H. and Greevie,N. (eds), Neurotoxicology. Raven Press, New York, NY, pp. 595-601.
37. Fischman,A.K., Roisin,L., Moralishvili,E., Allou,P., Ross,D. and Rainer,J.D. (1983) Clastogenic effects of heroin in pregnant monkeys and their offspring. Mutat. Res., 118, 77-89.
38. Friesen,M., O'Neill,I.K., Malaveille,C., Garren,L., Hautefeuille,A., Cabral,J.R.P., Lasne,C., Sala,M., Chouroulinkov,I., Mohr,U., Turusov,V., Day,N.E. and Bartsch,H. (1985) Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophageal cancer in Iran. Mutat. Res., 150, 177-191.
39. Friesen,M., O'Neill,I.K., Malaveille,C., Garren,L., Hautefeuille,A. and Bartsch,H. (1987) Substituted hydrophenanthrenes in opium pyrolysates implicated in oesophageal cancer in Iran: structures and in vitro metabolic activation of a novel class of mutagens. Carcinogenesis, 8, 1423-1432.
40. Fuchs,B.A. and Pruett,S.B. (1993) Morphine induces apoptosis in murine thymocytes in vivo but not in virro: involvement of both opiate and glucorticoid receptors. J. Phamacol. Exp. Ther., 266, 417-423.
41. Garg,U.C., Turndorf,H. and Bansinath,M. (1993) Effect of cocaine on macromolecular synthesis and cell proliferation in cultured glial cells. Neuroscience, 57, 467-472.
42. Gillogley,K.M., Evans,A.T., Hansen,R.L., Samuels,S.J. and Batra,K.K. (1990) The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am. J. Obstet. Gynecol., 163, 1535-1542.
43. Glare,P.A. and Walsh,T.D. (1991) Clinical pharmacokinetics of morphine. Ther. Drug Monitoring, 13, 1-23.
44. Graybiel,A.M., Moratalla,R. and Robertson,H.A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosomematrix compartments and limbic subdivisions of the striatum. Proc. Natl Acad. Sci. USA, 87, 6912-6916.
45. Gogas,K.R., Levine,J.D. and Basbaum,A.I. (1993) Mechanisms of opioid-mediated antinociception: correlation of FOS expression and behavior. NIDA Res. Monogr., 125, 134-160.
46. Grufferman,S., Schwartz,A.G., Ruymann,F.B. and Maurer,H.M. (1993) Parents' use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control, 4, 217-224.
47. Harris,P.D. and Garret,R. (1972) Susceptibility of addicts to infection and neoplasia. New Engl. J. Med., 287, 310.
48. Haverkos,H.W. (1988) Overview: HIV infection among intravenous drug abusers in the United States and Europe. NIDA Res. Monogr., 80, 7-17.
49. Henningfield,J.E., Clayton,R. and Pollin,W. (1990) Involvement of tobacco in alcoholism and illicit drug use. Br. J. Addiction, 85, 279-291.
50. Hewer,T., Rose,E., Ghadirian,P., Castegnaro,M., Malaveille,C., Bartsch,H. and Day,N. (1978) Ingested mutagens from opium and tobacco pyrolysis products and cancer of the esophagus. Lancet, ii, 494-496.
51. Hoffer,A. (1964) D-Lysergic acid diethylamide (LSD): a review of its present status. Clin. Pharmacol. Ther., 6, 183-255.
52. Holzman,C. and Paneth,N. (1994) Maternal cocaine use during pregnancy and perinatal outcomes. Epidemiol. Rev., 16, 315-334.
53. IARC (1985) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 37, Tobacco Habits Other than Smoking: Betel-nut and Areca-nut Chewing and Some Related Nitrosamines. International Agency for Research on Cancer, Lyon, France.
54. IARC (1986) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, Tobacco Smoking. International Agency for Research on Cancer. Lyon, France.
55. IARC (1988) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 44, Alcohol Drinking. International Agency for Research on Cancer. Lyon, France.
56. Inaba,T., Nebert,D.W., Burchell,B., Watkins,P.B., Goldstein,J.A., Bertilsson,L. and Tucker,G.T. (1995) Pharmacogenetics in clinical pharmacology and toxicology. Can. J. Physiol. Pharmacol., 73, 331-338.
57. Irwin,S. and Egozcue,J. (1967) Chromosome abnormalities in leukocytes from LSD users. Science, 157, 313-314.
58. Islam,M.W,. al-Shabanah,O.A., al-Harbi,M.M. and al-Gharably,N.M. (1994) Evaluation of teratogenic potential of khat (Catha edulis Forsk.) in rats. Drug Chem. Toxicol., 17, 51-68.
59. Jeng,J.H., Kuo,M.L., Hahn,L.J. and Kuo,M.Y.P. (1994) Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J. Dent. Res., 73, 1043-1049.
60. Johansson,B., Lindstrom,K. and Fredholm,B.B. (1994) Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience, 59, 837-849.
61. Johansson,I., Yue,Q.Y., Dahl,M.L., Heim, Säwe,J., Bertilsson,L., Meyer,U.A., Sjöqvist,F. and Ingelman-Sundberg,M. (1991) Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine. Ear. J. Clin. Pharmacol., 40, 553-556.
62. Kalix,P. (1991) The pharmacology of psychoactive alkaloids from ephedra and catha. J. Ethnopharmacol., 32, 201-208.
63. Kalix,P. (1992) Cathinone, a natural amphetamine. Pharmacol. Toxicol., 70, 77-86.
64. Kleber,H.D. (1991) Tracking the cocaine epidemic. The Drug Abuse Warning Network. J. Am. Med. Ass., 266, 2272.
65. Kmet,J. (1978) Opium and oesophageal cancer in Iran. Lancet, ii, 1371-1372.
66. Ko,Y.C., Huang,Y.L., Chen,M.J., Lin,L.M. and Tsai,C.C. (1995) Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J. Oral. Pathol. Med., 24, 450-453.
67. Krippner,S. (1970) Drug deceptions. Science, 168, 654-655.
68. Lee,N.M. and Loh,H.H. (1975) A study of deoxyribonucleic acid binding of narcotic analgesics. Biochem. Pharmacol., 24, 1249-1251.
69. Lee-Chen,S.-F., Chen,C.-L., Ho,L.-Y., Hsu,P.-C., Chang,J.-T., Sun,C.-M., Chi,C.-W. and Liu,T.-Y. (1996) Role of oxidative DNA damage in hydroxychavicol-induced genotoxicity. Mutagenesis, 11, 519-523.
70. Leuchtenberger,C., Leuchtenberger,R. and Ritter,U. (1973) Effects of marijuana and tobacco smoke on DNA and chromosomal complement in human lung explants. Nature, 242, 403-404.
71. Lin,L.Y., Kumagai,Y., Hiratsuka,A., Narimatsu,S., Suzuki,T., Funae,Y., Distefano,E.W. and Cho,A.K. (1995) Cytochrome p4502D isozyme catalyze the 4-hydroxytation of methamphetamine enatiomers. Drug Metab. Dispos., 23, 610-614.
72. Lipshultz,S.E., Frassica,J.J. and Orav,E.J. (1991) Cardiovascular abnormalities in infants prenatally exposed to cocaine. J. Pediat., 118, 44-51.
73. Little,J. and Vainio,H. (1994) Mutagenic lifestyles? A review of evidence of associations between germ-cell mutations in humans and smoking, alcohol consumption and use of 'recreational' drugs. Mutat. Res., 313, 131-151.
74. Mackler,S.A. and Eberwine,J.H. (1991) The molecular biology of addictive drugs. Mol. Neurobiol., 5, 45-58.
75. Madden,J.J. and Falek,A. (1991) The use of nonneuronal cells as an in vitro model system for studying the genetic component of cellular response to opiates and other drugs of abuse. J. Addictive Dis., 10, 229-238.
76. Madden,J.J., Falek,A., Shafer,D.A. and Glick,J.H. (1979) Effects of opiates and demographic factors on DNA repair synthesis in human leukocytes. Proc. Natl Acad. Sci. USA, 76, 5769-5773.
77. Marley,R.J., Elmer,G.I. and Goldberg,S.R. (1992) The use of pharmacologic techniques in drug abuse research. Pharmacol. Ther., 53, 217-237.
78. Marley,R.J., Shimosato,K., Elmer,G.I. and Miner,L.L. (1993) Pharmacogenetic approaches to drug dependence. Biochem. Soc. Symp., 59, 153-172.
79. Martin,S.J., Green,D.R. and Cotter,T.G. (1994) Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem. Sci., 19, 26-30.
80. McCann,J., Choi,E., Yamasaki,E. and Ames,B.N. (1975) Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl Acad. Sci. USA, 72, 5135-5139.
81. Mikus,G., Ulmer,A., Griese,E.U. and Hofmann,U. (1994) Identification of the enzyme involved in dihydrocodeine O-methylation to dihydromorphine. Arch. Pharmacol., 349, R143.
82. Morgan,B., Brake,S.C., Hutchings,D.E., Miller,N. and Gamagaris,Z. (1988) Delta-9-tetrahydrocannabinol during pregnancy in the rat: effects on development of RNA, DNA, and protein in offspring brain. Pharmacol. Biochem. Behav., 31, 365-369.
83. Nahas,G. and Latour,C. (1992) The human toxicity of marijuana. Med. J. Aust., 156, 495-497.
84. Nair,J., Ohshima,H., Friesen,M., Croisy,A., Bhide,S.V. and Bartsch,H. (1985) Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis, 6, 295-303.
85. Nair,U.J., Floyd,R.A., Nair,J., Bussachini,V., Friesen,M. and Bartsch,H. (1987) Formation of reactive oxygen species and of 8-hydroxy-deoxyguanosine in DNA in vitro with betel quid ingredients. Chemico-Biol. Interact., 63, 157-169.
86. Nair,U.J., Friesen,M., Richard,I., MacLennan,R., Thomas,S. and Bartsch,H. (1990) Effect of lime composition on the formation of reactive oxygen species from areca nut extract in vitro. Carcinogenesis, 11, 2145-2148.
87. Nair,U.J., Obe,G., Friesen,M., Goldberg,M.T. and Bartsch,H. (1992) Role of lime in the generation of reactive oxygen species from betel-quid ingredients. Environ. Hlth Perspect., 98, 203-205.
88. Nassogne,M.-C., Louahed,J., Evrard,P. and Courtoy,P.J. (1997) Cocaine induces apoptosis in cortical neurons of fetal mice. J. Neurochem., 68, 2442-2450.
89. Nguyen,T.V., Kosofsky,B.E., Birnbaum,R., Cohen,B.M. and Hyman,S.E. (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl Acad. Sci. USA, 89, 4270-4274.
90. Nichols,W.W. (1966) Studies on the role of viruses in somatic mutation. Hereditas, 55, 1-27.
91. Nishikawa,A., Prokopczky,B., Rivenson,A., Zang,E. and Hoffmann,D. (1992) A study of betel quid carcinogenicity of 3-(methylnitrosoamino)propionaldehyde in F344 rats. Carcinogenesis, 13, 369-372.
92. NTP (1996) National Toxicology Program Technical Report Series, No.455, Toxicology and Carcinogenesis Studies of Codeine in F344/N Rats and B6C3F1 Mice. Public Health Service, US Department of Health and Human Services, National Institutes of Health, Bethesda, MD.
93. Otton,S.V., Schadel,M., Cheung,S.W., Kaplan,H.L., Busto,U.E. and Sellers,E.M. (1993) CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphine. Clin. Pharmacol. Ther., 54, 463-472.
94. Owens,S.M., Gunnell,M., Laurenzana,E.M. and Valentine,J.L. (1993) Dose dependent and time dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1. J. Pharmacol. Exp. Ther., 265, 1261-1266.
95. Panigrahi,G.B. and Rao,A.R. (1982) Chromosome-breaking ability of arecoline, a major betel-nut alkaloid, in mouse bone-marrow cells in vivo. Mutat. Res., 103, 197-204.
96. Panigrahi,G.B. and Rao,A.R. (1984) Induction of in vivo sister chromatid exchanges by arecaidine, a betel nut alkaloid, in mouse bone-marrow cells. Cancer Lett., 23, 189-192.
97. Persico,A.M., Schindler,C.W., O'Hara,B.F., Brannock,M.T. and Uhl,G.R. (1993) Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Mol. Brain Res., 20, 91-100.
98. Prokopczky,B., Rivenson,A., Bertinato,P., Brunnemann,K.D. and Hoffmann,D. (1987) 3-(Methylnitrosoamino)propionitrile: occurrence in saliva of betel quid chewers, carcinogenicity, and DNA methylation in F344 rats. Cancer Res., 47, 467-471.
99. Prokopczky,B., Rivenson,A. and Hoffmann,D. (1991) A study of betel quid carcinogenesis IX. Comparative carcinogenicity of 3-(methylnitrosoamino)propionitrile and 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone upon local application to mouse skin and rat oral mucosa. Cancer Lett., 60, 153-157.
100. Ribeiro,P.L.F. and Swann,P.F. (1997) Opium and oesophageal cancer: effect of morphine and opium on the metabolism of N-nitrosodimethylamine and N-nitrosodiethylamine in the rat. Carcinogenesis, 18, 365-369.
101. Robison,L.L., Buckley,J.D. and Daigle,A.E. (1989) Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Children's Cancer Study Group). Cancer, 63, 1904-1910.
102. Rosenkranz,H.S. and Klopman,G. (1990) The carcinogenic potential of cocaine. Cancer Lett., 52, 243-246.
103. Sadeghi,A., Behmard,S. and Vesselinovitch,S.D. (1979) Opium: a potential urinary bladder carcinogen in man. Cancer, 43, 2315-2321.
104. Sapira,J.D., Ball,J.C. and Penn,H. (1970) Causes of death among institutionalized narcotic addicts. J. Chronic Dis., 22, 733-742.
105. Sastry,B.V. (1991) Placental toxicology: tobacco smoke, abused drugs, multiple chemical interactions, and placental function. Reprod. Fertil. Dev., 3, 355-372.
106. Sawant,S.G. and Couch,D.B. (1995) Induction of micronuclei in murine lymphocytes. Environ. Mol. Mutagen., 25, 179-283.
107. Schwetz,B.A. and Casciano,D.A. (1998) Genetic toxicology: impact on the next generation of toxicology. Environ. Mol. Mutagen., 31, 1-3.
108. Shafer,D.A., Falek,A., Madden,J.J., Tadayon,F., Pline,M., Bokos,P.J., Kuelule,J.C. and Mendelson,J. (1983) Parallel increases in sister-chromatid exchanges at base level and with UV treatment in human opiate users. Mutat. Res., 109, 73-82.
109. Shafer,D.A., Xie,Y. and Falek,A. (1994) Detection of opiate-enhanced increases in DNA damage, HPRT mutants, and mutation frequency in human HUT-78 cells. Environ. Mol. Mutagen., 23, 37-44.
110. Sherman,M.P., Aeberhard,E.E., Wong,V.Z., Simmons,M.S., Roth,M.D. and Tashkin,D.P. (1995) Effects of smoking marijuana, tobacco or cocaine alone or in combination on DNA damage in human alveolar macrophages. Life Sci., 56, 2201-2207.
111. Shirname,L.P., Menon,M.M., Nair,J. and Bhide,S.V. (1983) Correlation of mutagenicity and tumorigenicity of betel quid and its ingredients. Nutr. Cancer, 5, 87-91.
112. Shirname,L.P., Menon,M.M. and Bhide,S.V. (1984) Mutagenicity of betel quid and its ingredients using mammalian test systems. Carcinogenesis, 5, 501-503.
113. Shuster,L. (1984) Genetic determinants of response to drugs of abuse: an evaluation of research strategies. NIDA Res. Monogr., 54, 50-59.
114. Singh,M.P., Kalia,C.S. and Jain,H.K. (1970) Chromosomal aberrations induced in barley by LSD. Science, 169, 491-192.
115. Smith,M.V. (1981) Psychodelic Chemistry. Loompanics Unlimited, Port Townsend, WA.
116. Smythies,J.R. and Antun,F. (1969) Binding of tryptamine and allied compounds to nucleic acids. Nature, 223, 1061-1063.
117. Soufi,H.E., Kameswaran,M. and Malatani,T. (1991) Khat and oral cancer. J. Laryngol. Otol., 105, 643-645.
118. Sram,R.J. and Goetz,P. (1974) The mutagenic effect of lysergic acid diethylamide. III. Evaluation of the genetic risk of LSD in man. Mutat. Res., 26, 523-528.
119. Sram,R.J., Zudova,Z. and Goetz,P. (1974) The mutagenic effect of lysergic acid diethylamide. II. Dominant lethal test in mice. Mutat. Res., 26, 517-522.
120. Stich,H.F., Rosin,M.P. and Brunnemann,K.D. (1986) Oral lesions, genotoxicity and nitrosamines in betel quid chewers with no obvious increase in oral cancer risk. Cancer Lett., 31, 15-25.
121. Swain,N., Das,R.K. and Paul,M. (1980) Cytogenetic assay of potential mutagenicity in vivo of two narcotic analgesics. Mutat. Res., 78, 97-100.
122. Szara,S.I. (ed.) (1986) Neurobiology of behavioral control in drug abuse. NIDA Res. Monogr., 74, 1-5.
123. 1 opioid receptor mechanism. Science, 276, 2048-2050.
124. Tarig,M., Qureshi,S., Ageel,A.M. and aJ-Meshal,I.A. (1990) The induction of dominant lethal mutations upon chronic administration of khat (Catha edulis) in albino mice. Toxicol. Lett., 50, 349-353.
125. Troyer,H. (1988) Review of cancer among 4 religious sects: evidence that life-styles are distinctive sets of risk factors. Soc. Sci. Med., 26, 1007-1017.
126. Uhl,G.R. and Persico,A. (1994) Meeting report: collaborative approaches in drug abuse genetics. Drug Alcohol Dependence, 34, 161-162.
127. Ulrich,R. and Patten,B. (1991) The rise, decline and fall of LSD. Perspect. Biol. Med., 34, 561-578.
128. Vann,E., Matheu,C. and Rossmoore,H. (1970) Genetic effect of LSD on E. coli. Mutat. Res., 10, 369-375.
129. Vega,W.A., Kolody,B., Hwang,J. and Noble,A. (1993) Prevalence and magnitude of perinatal substance exposures in California. New Engl. J. Med., 329, 850-854.
130. Volpe,J.J. (1992) Effect of cocaine use on the fetus. New Engl. J. Med., 327, 399-407.
131. Wagner,T.E. (1969) In vitro interaction of LSD with purified calf thymus DNA. Nature, 222, 1170-1172.
132. Wenke,G. and Hoffmann,D. (1983) A study of betel quid carcinogenesis. 1. On the in vitro N-nitrosation of arecoline. Carcinogenesis, 4, 169-172.
133. Wenke,G., Brunnemann,K.D., Hoffmann,D. and Bhide,S.V. (1984a) A study of betel quid carcinogenesis IV. Analysis of the saliva of betel chewers: a preliminary report. J. Cancer Res. Clin. Oncol., 108, 110-113.
134. Wenke,G., Rivenson,A. and Hoffmann,D. (1984b) A study of betel quid carcinogenesis. III. 3-(Methylnitrosoamino)propiontrile, a powerful carcinogen in F344 rats. Carcinogenesis, 5, 1137-1140.
135. Wetherington,C.L., Smeriglio,V.L. and Finnegan,L.P. (eds) (1996) Behavioral studies of drug-exposed offspring: methodological issues in human and animal research. NIDA Res. Monogr., 164, 1-2.
136. Wickelgren,I. (1997) Marijuana: harder than thought? Science, 276, 1967-1978.
137. Zhang,Y.P., Sussman,N., Macina,O.T., Rosenkraz,H.S., Klopman,G. (1996) Prediction of the carcinogenicity of a second group of organic chemicals undergoing carcinogenicity testing. Environ. Hlth Perspect., 104 (suppl. 5), 1045-1050.
138. Zimmerman,S. and Zimmerman,A.M. (1991) Genetic effects of marijuana. Int. J. Addictions, 25 (1A), 19-33.